Management and treatment of children, young people and adults with systemic lupus erythematosus: British Society for Rheumatology guideline scope
Md Yuzaiful Md Yusof(University of Leeds), Edward M Vital(University of Leeds), Arvind Kaul(St George’s University Hospitals NHS Foundation Trust), Bridget Griffiths(Freeman Hospital), Clarissa Pilkington(Great Ormond Street Hospital), Philip Laws(Leeds Teaching Hospitals NHS Trust), Christian Mallen(Keele University), Rebecca Gilman(University of Birmingham), Lindsey Cherry(University of Southampton), Heather Rostron(University of Leeds), Michael W. Beresford(University of Liverpool), Caroline Gordon(University of Birmingham), Antonios Psarras(Nuffield Orthopaedic Centre), Eve Smith(University of Liverpool), Dalila Tremarias(LUPUS UK), Jade Skeates(Royal National Hospital for Rheumatic Diseases), Sammy Ainsworth(LUPUS UK), Peter Lanyon(Nottingham University Hospitals NHS Trust), Elena Moraitis(Great Ormond Street Hospital), Paul Howard(LUPUS UK), Hanna Lythgoe(Manchester University NHS Foundation Trust), Sarah Skeoch(Royal National Hospital for Rheumatic Diseases), Clare Nash(Sheffield Children's NHS Foundation Trust), David Isenberg(Regenerative Medicine Institute), Stephen D. Marks(Great Ormond Street Hospital), Naomi Maxwell(LUPUS UK), Christopher J Edwards(University Hospital Southampton NHS Foundation Trust), Chris Wincup(King's College Hospital), Kate Armon(Cambridge University Hospitals NHS Foundation Trust), Liz Lightsone(Imperial College London), Natasha Jordan(King's College London), Asad Zoma(NHS Lanarkshire), Morgan Brown(LUPUS UK), Ruth J. Pepper(University College Hospital), Kalveer Flora(London North West Healthcare NHS Trust)
Cited by 8
Related Papers
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
|Annals of the Rheumatic Diseases|2020|2.8k
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
|Annals of the Rheumatic Diseases|2022|1.9k
2022 update
|Radboud Repository (Radboud University)|2010|1.6k
EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis
|Annals of the Rheumatic Diseases|2013|1.4k